TrialTechnology in cancer research & treatment2019

Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy.

Li Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.